/People

Stephen Bloch

Investor

General Partner / East Coast at Canaan Partners · Special Advisor at JSD Capital, LLC

Westport, Connecticut

Writes $250K – $20M checks · typically $10M

Kauffman Fellow · Class 7

Find your path to Stephen

Sign up to see every warm intro you have to Stephen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Stephen. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.

Contact· self-published, not guessed

Invests in

BiotechConsumerDeep TechDigital HealthEnterprise SoftwareFintechHardwareHealthtechMedical Devices

Beyond investing

Founded
Stephen Bloch helped found and manage Radiology Management Sciences (RMS), OmniSonics Medical Technologies, and TeleRad.
Boards
Stephen Bloch is a member of Dartmouth Medical School's Board of Advisors.
More
Stephen Bloch is a former practicing physician.

From published sources — common ground for a warm intro.

Deals · 6

Liquidia CorporationBoard seat

via Canaan Partners · filed Apr 2021 · $21.7M raise

IantrekBoard seat

via Canaan Partners · filed Oct 2020 · $5.2M raise

Liquidia TechnologiesBoard seat

via Canaan Partners · filed Jan 2020 · $22.4M raise

Dicom GridBoard seat

via Canaan Partners · filed Nov 2017 · $7.4M raise

TruverisBoard seat

via Canaan Partners · filed Aug 2017 · $34.7M raise

Envisia TherapeuticsBoard seat

via Canaan Partners · filed Oct 2015 · $5.1M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: curated public sources · SEC Form D filings · the firm's website.

Colleagues at Canaan Partners

Network3

Investors connected to Stephen in public investor directories — a warm-intro map.

Frequently asked questions

Who is Stephen Bloch?
Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
Where does Stephen Bloch work?
Stephen Bloch is General Partner / East Coast at Canaan Partners and Special Advisor at JSD Capital, LLC.
What does Stephen Bloch invest in?
Stephen Bloch invests in Biotech, Consumer, Deep Tech, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
What check size does Stephen Bloch write?
Stephen Bloch typically writes checks of $250K – $20M.
What boards does Stephen Bloch sit on?
Stephen Bloch holds tracked board seats at Ambra Health, Amicus Therapeutics, Corvium, Dicom Grid, Envisia Therapeutics, Genome Medical, Genome Medical, Iantrek, Liquidia, Liquidia Corporation.
What companies has Stephen Bloch invested in?
Investments tracked here include Advanced BioHealing, Ambra Health, Amicus Therapeutics, Corvium, Envisia Therapeutics, Envisia Therapeutics, Genome Medical, Inc., Liquidia Corporation, Liquidia Technologies, Marinus Pharmaceuticals, Onkos Surgical, Sample6, and 1 more.

Founder mafias

About this profile. Compiled from public sources — Canaan Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights